Structural characterization of substrate and inhibitor binding to farnesyl pyrophosphate synthase fromPseudomonas aeruginosa
出版年份 2015 全文链接
标题
Structural characterization of substrate and inhibitor binding to farnesyl pyrophosphate synthase fromPseudomonas aeruginosa
作者
关键词
-
出版物
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
Volume 71, Issue 3, Pages 721-731
出版商
International Union of Crystallography (IUCr)
发表日期
2015-02-27
DOI
10.1107/s1399004715001121
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multistage Screening Reveals Chameleon Ligands of the Human Farnesyl Pyrophosphate Synthase: Implications to Drug Discovery for Neurodegenerative Diseases
- (2014) Joris W. De Schutter et al. JOURNAL OF MEDICINAL CHEMISTRY
- Taxodione and arenarone inhibit farnesyl diphosphate synthase by binding to the isopentenyl diphosphate site
- (2014) Y.-L. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural and thermodynamic basis of the inhibition ofLeishmania majorfarnesyl diphosphate synthase by nitrogen-containing bisphosphonates
- (2014) Srinivas Aripirala et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Farnesyl Diphosphate Synthase Inhibitors fromIn SilicoScreening
- (2013) Steffen Lindert et al. Chemical Biology & Drug Design
- DEG 10, an update of the database of essential genes that includes both protein-coding genes and noncoding genomic elements: Table 1.
- (2013) Hao Luo et al. NUCLEIC ACIDS RESEARCH
- Farnesyl pyrophosphate synthase: a key enzyme in isoprenoid biosynthetic pathway and potential molecular target for drug development
- (2012) Manoj K. Dhar et al. New Biotechnology
- iMOSFLM: a new graphical interface for diffraction-image processing withMOSFLM
- (2011) T. Geoff G. Battye et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- REFMAC5 for the refinement of macromolecular crystal structures
- (2011) Garib N. Murshudov et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Bisphosphonates: The first 40years
- (2011) R. Graham G. Russell BONE
- Targeting Isoprenoid Biosynthesis for Drug Discovery: Bench to Bedside
- (2010) Eric Oldfield ACCOUNTS OF CHEMICAL RESEARCH
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Nitrogen-Containing Bisphosphonates and Cancer Immunotherapy
- (2010) P. Clezardin et al. CURRENT PHARMACEUTICAL DESIGN
- High-throughput production of human proteins for crystallization: The SGC experience
- (2010) Pavel Savitsky et al. JOURNAL OF STRUCTURAL BIOLOGY
- Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery
- (2010) Wolfgang Jahnke et al. Nature Chemical Biology
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Lipophilic Bisphosphonates as Dual Farnesyl/Geranylgeranyl Diphosphate Synthase Inhibitors: An X-ray and NMR Investigation
- (2009) Yonghui Zhang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Binding of nitrogen-containing bisphosphonates (N-BPs) to the Trypanosoma cruzi farnesyl diphosphate synthase homodimer
- (2009) Chuan-Hsiang Huang et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- A knowledge-driven approach for crystallographic protein model completion
- (2008) Krista Joosten et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
- (2008) R. G. G. Russell et al. OSTEOPOROSIS INTERNATIONAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started